HCA Healthcare Inc (HCA) Holdings Lowered by Achmea Investment Management B.V.

Achmea Investment Management B.V. cut its position in HCA Healthcare Inc (NYSE:HCA) by 26.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 52,959 shares of the company’s stock after selling 18,729 shares during the period. Achmea Investment Management B.V.’s holdings in HCA Healthcare were worth $7,366,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in the business. FMR LLC grew its position in shares of HCA Healthcare by 54.9% in the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock valued at $563,097,000 after buying an additional 1,944,961 shares during the last quarter. LSV Asset Management grew its position in shares of HCA Healthcare by 9.2% in the 2nd quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock valued at $560,133,000 after buying an additional 457,752 shares during the last quarter. Northern Trust Corp grew its position in shares of HCA Healthcare by 4.2% in the 2nd quarter. Northern Trust Corp now owns 3,460,267 shares of the company’s stock valued at $355,023,000 after buying an additional 138,135 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in shares of HCA Healthcare by 98.3% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,767,715 shares of the company’s stock valued at $245,925,000 after buying an additional 876,226 shares during the last quarter. Finally, Millennium Management LLC grew its position in shares of HCA Healthcare by 32.3% in the 2nd quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock valued at $174,270,000 after buying an additional 414,877 shares during the last quarter. 70.84% of the stock is currently owned by institutional investors.

In other news, SVP Deborah M. Reiner sold 723 shares of the firm’s stock in a transaction on Monday, November 5th. The shares were sold at an average price of $135.06, for a total value of $97,648.38. Following the completion of the sale, the senior vice president now owns 6,184 shares in the company, valued at approximately $835,211.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Jane D. Englebright sold 6,543 shares of the firm’s stock in a transaction on Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total transaction of $849,673.98. Following the completion of the sale, the senior vice president now owns 7,443 shares of the company’s stock, valued at approximately $966,547.98. The disclosure for this sale can be found here. Insiders sold a total of 12,462 shares of company stock valued at $1,656,680 in the last 90 days. Company insiders own 2.80% of the company’s stock.

A number of research firms recently commented on HCA. JPMorgan Chase & Co. increased their target price on shares of HCA Healthcare to $151.00 and gave the company an “overweight” rating in a research report on Monday, July 30th. SunTrust Banks increased their target price on shares of HCA Healthcare to $150.00 and gave the company a “positive” rating in a research report on Tuesday, September 4th. Mizuho reissued a “buy” rating and set a $145.00 price objective on shares of HCA Healthcare in a research report on Thursday, August 2nd. Leerink Swann raised their price objective on shares of HCA Healthcare from $125.00 to $140.00 and gave the stock an “outperform” rating in a research report on Thursday, July 26th. Finally, Argus raised their price objective on shares of HCA Healthcare to $150.00 and gave the stock a “buy” rating in a research report on Friday, September 7th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $141.53.

Shares of HCA Healthcare stock opened at $141.63 on Friday. HCA Healthcare Inc has a 1 year low of $74.26 and a 1 year high of $143.02. The firm has a market cap of $46.80 billion, a price-to-earnings ratio of 21.49, a price-to-earnings-growth ratio of 1.19 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The company had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.29 billion. During the same period last year, the firm posted $1.13 EPS. HCA Healthcare’s revenue for the quarter was up 7.1% on a year-over-year basis. As a group, equities analysts anticipate that HCA Healthcare Inc will post 9.35 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Stockholders of record on Monday, December 3rd will be paid a $0.35 dividend. This represents a $1.40 annualized dividend and a dividend yield of 0.99%. The ex-dividend date is Friday, November 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.

ILLEGAL ACTIVITY WARNING: “HCA Healthcare Inc (HCA) Holdings Lowered by Achmea Investment Management B.V.” was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://sportsperspectives.com/2018/11/09/hca-healthcare-inc-hca-holdings-lowered-by-achmea-investment-management-b-v.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Buyback For Investors Defined

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply